Begin typing your search above and press return to search.
Greetings to the City of Literature
access_time 24 Jun 2024 5:25 AM GMT
The saffronized corruption in examinations
access_time 22 Jun 2024 4:00 AM GMT
Buds and brains
access_time 21 Jun 2024 6:34 AM GMT
Is Europe leaning to the right?
access_time 20 Jun 2024 6:28 AM GMT
Homechevron_rightLifestylechevron_rightHealthchevron_rightIndia to launch first...

India to launch first Covid nasal vaccine on January 26

covid vaccine

New Delhi: Bharat Biotech is all set to launch its intranasal COVID-19 vaccine iNCOVACC on January 26. This is the first of its kind in the country, said the company's chairman and managing director Krishna Ella.

"Our nasal vaccine will be officially launched on January 26, on Republic Day." He was speaking at the India International Science Festival in Bhopal during the 'New Frontiers in Science' segment organised at the Maulana Azad National Institute of Technology (MANIT).

The homegrown company announced in December that it will sell the intranasal vaccine for Rs 325 per shot for procurement by the government and Rs 800 per shot for private vaccination centres.

The vaccine will be used as a heterologous booster. It will be first available in private hospitals. It received approval from the Drugs Controller General of India in November for restricted use in an emergency situation for those above 18.

An intranasal vaccine stimulates a broad immune response - neutralising IgG, mucosal IgA, and T cell responses. The immune response at the nasal mucosa which is the site of infection is crucial to blocking infection and transmission of Covid-19.

Show Full Article
TAGS:covid vaccineBharat BiotechCovid nasal vaccine
Next Story